QT Ultrasound

What QT Ultrasound does

QT Imaging Holdings, Inc. (also known as QT Ultrasound) is a US-based medical device company founded in 2011 and headquartered at Three Hamilton Landing, Suite 160, Novato, California. The company develops and commercializes the QTI Breast Acoustic CT Scanner, a radiation-free breast imaging platform that combines Quantitative Transmission (QT) ultrasound with proprietary image reconstruction software, AI-powered lesion classification, and quantitative tissue biomarkers generated from speed-of-sound maps. The platform delivers non-ionizing, no-compression, high-resolution 3D imaging and is positioned primarily for women with dense breast tissue (40-50% of women ages 40-74 in the US), patients with MRI contraindications, and women with breast implants, addressing well-documented limitations of X-ray mammography.

QT Imaging generates revenue across three streams: hardware sales of the QTI Breast Acoustic CT Scanner to healthcare facilities, software licensing through its QTviewer Software for image viewing and analysis, and imaging services revenue from clinical procedures performed at partner facilities. The company operates an enterprise field sales go-to-market, selling directly to hospitals, breast care centers, and medical practices, supported by content marketing, social media presence on LinkedIn and Instagram, industry conference participation, and patient testimonial video. Operating geographies include the United States and the United Kingdom, with named customers including Center For New Medicine and practicing physician Dr. Leigh Erin Connealy. The company holds FDA 510(k) clearances and in 2026 completed its first FDA routine inspection with zero Form 483 observations, positioning it within a global breast cancer imaging market projected to grow from $2.1 billion in 2024 to $4.0 billion by 2033.

Name

QT Ultrasound

Legal name

QT Imaging Holdings, Inc.

Website

https://qtultrasound.com

Company type

Public

Founded year

2011

Operating status

Operating

Headcount range

51–100 employees

Short description

QT Imaging Holdings, Inc. (QT Ultrasound) is a Novato, California-based medical device company that develops and sells the FDA-cleared QTI Breast Acoustic CT Scanner, a radiation-free, no-compression 3D breast imaging platform combining Quantitative Transmission ultrasound, AI lesion classification, and quantitative biomarkers for hospitals, breast centers, and medical practices.

Ownership category

akta.pro rank

Headquarters

HQ city

Novato

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of QTI Breast Acoustic CT Scanner to healthcare facilities
2. Software Licensing: QTviewer Software for image viewing and analysis
3. Imaging Services: Revenue from clinical imaging procedures performed at partner facilities

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

QT Imaging develops and sells the QTI Breast Acoustic CT Scanner, a medical imaging device that uses Quantitative Transmission (QT) ultrasound combined with AI and tissue biomarkers to perform radiation-free, no-compression, high-resolution 3D breast imaging for cancer screening and diagnosis. The company also licenses QTviewer Software for cloud-based image viewing, analysis, and reporting of breast scans captured by the scanner. Products are sold to healthcare facilities and clinical providers for use in breast health programs.

Product overview

QT Imaging offers a unified platform combining the QTI Breast Acoustic CT™ Scanner as the core imaging device with QTviewer Software for image analysis. The platform integrates Quantitative Transmission (QT) ultrasound technology, AI-powered lesion classification, and quantitative tissue biomarkers generated from speed-of-sound maps to deliver radiation-free, high-resolution 3D breast imaging. The system addresses limitations of traditional mammography, particularly for women with dense breast tissue, and supports applications from screening to diagnostic imaging.

Differentiator

Problem solved

Functional benefit

Brands

• QTI Breast Acoustic CT Scanner: The company's flagship medical device - a radiation-free, non-compressing 3D breast imaging scanner using quantitative transmission ultrasound technology.
• QTviewer Software

Products and services

• QTI Breast Acoustic CT Scanner Medical imaging hardware device for breast cancer detection, providing non-ionizing, no-compression, high-resolution 3D imaging of the breast using Quantitative Transmission ultrasound combined with AI-powered lesion classification and tissue biomarkers; sold to hospitals, breast care centers, and medical practices for clinical use.
• QTviewer Software Viewing and analysis software for reviewing breast imaging scans captured by the QTI Breast Acoustic CT Scanner, providing cloud-based image analytics and reporting for clinicians.

Quantifiable outcome

• Global breast cancer incidence expected to rise by 38% and related deaths by 68% by 2050

Named customers2 records

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

One partnership is on record.

• Strategic PartnerscoreOthersQT Imaging has a dedicated Strategic Partners page on their website indicating partner relationships in their go-to-market strategy, though specific partner names are not detailed in the provided source content.

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Emerging players

• Volpara Health: Volpara provides AI-driven breast density assessment and reporting software integrated with mammography. While software-only, it competes for the same dense-breast patient workflow and AI-based lesion risk stratification where QT is positioning its biomarkers.
• Densitas: Densitas provides AI-based breast density and image quality analytics for mammography programs. It addresses the same dense-breast clinical problem QT targets, although it works on existing mammograms rather than as a replacement modality.
• iCAD: iCAD offers ProFound AI, an AI-based breast cancer risk and lesion detection platform used alongside mammography. It is a relevant peer in AI-powered breast image analysis that QT competes with on the AI/software layer.
• Seno Medical Instruments: Seno Medical offers Imagio, an optoacoustic/ultrasound hybrid breast imaging system designed to help clinicians distinguish benign from malignant lesions without ionizing radiation. It targets the same radiation-free, dense-breast use cases as QT.

Broad incumbents

• Siemens Healthineers: Siemens Healthineers provides mammography (MAMMOMAT), ultrasound, and MRI breast imaging, alongside AI tools for breast care. It overlaps with QT on the screening and diagnostic breast imaging workflow served to hospitals and imaging centers.
• Hologic: Hologic is the dominant player in breast cancer screening via its 3D mammography (Selenia Dimensions) and Genius AI platforms. It is the primary incumbent QT competes against in the breast imaging modality, with a deeply installed base and established reimbursement.
• Fujifilm Healthcare: Fujifilm's Healthcare division offers digital mammography (Amulet Innovality), ultrasound, and women's health imaging. It is a relevant incumbent competitor in breast imaging modalities where QT is positioning its scanner.
• GE HealthCare: GE HealthCare offers a broad portfolio of mammography, ultrasound, and AI-enabled breast imaging solutions (e.g., Senographe, Invenia ABUS). It competes with QT across multiple breast imaging modalities and possesses far greater scale and global distribution.
• Philips: Philips offers mammography, ultrasound, and MRI breast imaging as part of its broader diagnostic imaging portfolio, with AI-enabled workflow tools. It is a broad incumbent competitor in breast imaging hardware and informatics where QT operates.

Direct peers

• Delphinus Medical Technologies: Delphinus developed the SoftVue whole breast ultrasound tomography system, a radiation-free, no-compression 3D breast imaging modality. It is one of the closest direct competitors to QT's QTI Breast Acoustic CT Scanner in the alternative-breast-imaging space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/qt-imaging-holdings
• Instagraminstagram.com/qtimaging
• Xx.com/qtbreasthealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QT Ultrasound